KYNB
Kyntra Bio, Inc. Common Stock
KYNB
KYNB
144 hedge funds and large institutions have $767M invested in Kyntra Bio, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 51 increasing their positions, 43 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.01% less ownership
Funds ownership: 1.95% → 1.95% (-0.01%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
52% less call options, than puts
Call options by funds: $4.08M | Put options by funds: $8.42M
Holders
144
Holding in Top 10
2
Calls
$4.08M
Puts
$8.42M
Top Buyers
| 1 | +$109M | |
| 2 | +$9.68M | |
| 3 | +$5.55M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$5.3M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$4.92M |
Top Sellers
| 1 | -$17.7M | |
| 2 | -$15.9M | |
| 3 | -$7.18M | |
| 4 |
Morgan Stanley
New York
|
-$3.28M |
| 5 |
NC
Nexthera Capital
New York
|
-$2.48M |